Drotaverine Hydrochloride + Mefenamic AcidThird Party Manufacturing in India

Drotaverine Hydrochloride and Mefenamic Acid is a fixed-dose combination that provides dual-action relief from spasmodic pain through two complementary mechanisms. Drotaverine Hydrochloride is a benzylisoquinoline derivative and a selective inhibitor of phosphodiesterase 4 (PDE4), the enzyme responsible for the degradation of cyclic adenosine monophosphate (cAMP) in smooth muscle cells. By inhibiting PDE4, drotaverine increases intracellular cAMP levels, which in turn activates myosin light-chain kinase (MLCK) phosphorylation. This phosphorylation reduces MLCK's affinity for the calcium-calmodulin complex, keeping MLCK in its inactive form and leading to smooth muscle relaxation. Unlike anticholinergic antispasmodics, drotaverine acts directly on smooth muscle regardless of autonomic innervation, making it effective across gastrointestinal, biliary, urinary tract, and uterine smooth muscle without significant cardiovascular side effects. Mefenamic Acid, a member of the fenamate class of NSAIDs, works by inhibiting cyclooxygenase enzymes COX-1 and COX-2, thereby blocking the synthesis of prostaglandins that mediate inflammation, pain, and fever. By reducing prostaglandin production at the site of tissue injury or spasm, mefenamic acid provides potent analgesic and anti-inflammatory effects. Together, drotaverine relieves the smooth muscle spasm while mefenamic acid addresses the associated inflammatory pain.

Therapeutic Uses

Drotaverine Hydrochloride + Mefenamic Acid combination is prescribed for the treatment of painful conditions involving smooth muscle spasm and inflammation:

• Primary Dysmenorrhea: This combination is highly effective for menstrual cramps, where drotaverine relaxes uterine smooth muscle spasms and mefenamic acid reduces prostaglandin-mediated menstrual pain and inflammation.
• Gastrointestinal Spasms: It provides relief from abdominal colic, irritable bowel syndrome-associated cramping, and gastritis-related pain where smooth muscle spasm is a contributing factor.
• Biliary and Renal Colic: The antispasmodic action of drotaverine helps relieve the intense pain caused by spasms of the biliary ducts and urinary tract, including kidney stone-related colic.
• Musculoskeletal Pain with Muscle Spasm: The combination addresses conditions where both muscle spasm and inflammatory pain coexist, such as low back pain and tension-type headaches.

Why Manufacturers Choose Drotaverine + Mefenamic Acid

This combination is one of the most widely prescribed antispasmodic-analgesic formulations in India and across emerging markets. Its popularity stems from its proven efficacy, favorable safety profile, and the absence of significant anticholinergic side effects that limit other antispasmodics. The tablet formulation at 80mg+250mg strength is a high-volume, fast-moving SKU in the Indian pharmaceutical market, with consistent demand from both the domestic retail segment and export markets in Africa, Asia, and the Middle East. Indian third-party manufacturers produce millions of tablets annually under WHO-GMP compliance, offering competitive pricing while maintaining stringent quality standards.

This makes Drotaverine Hydrochloride + Mefenamic Acid one of the most sought-after combination products for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.